Jeon, M. Y., Kim, B. K., Lee, J. S., Lee, H. W., Park, J. Y., Kim, D. Y., . . . Kim, S. U. (2021). Negligible risks of hepatocellular carcinoma during biomarker-defined immune-tolerant phase for patients with chronic hepatitis B. Clin Mol Hepatol.
Citação norma ChicagoJeon, Mi Young, Beom Kyung Kim, Jae Seung Lee, Hye Won Lee, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, and Seung Up Kim. "Negligible Risks of Hepatocellular Carcinoma During Biomarker-defined Immune-tolerant Phase for Patients With Chronic Hepatitis B." Clin Mol Hepatol 2021.
ציטוט MLAJeon, Mi Young, et al. "Negligible Risks of Hepatocellular Carcinoma During Biomarker-defined Immune-tolerant Phase for Patients With Chronic Hepatitis B." Clin Mol Hepatol 2021.